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Abstract: Polymorphisms that occur in the CYP1A1, CYP17 and TNF-α genes affects hyperkeratinzation process, se-
bum production and inflammation in acne vulgaris. Polymorphisms of CYP1A1, CYP17 and TNF-α genes can be identified 
by using PCR and sequencing techniques. The aim of this study is to demonstrate the role of polymorphisms of CYP1A1, 
CYP17, and TNF-α genes and the interaction polimorphisms of CYP1A1, CYP17 and TNF-α genes to severe acne vulgaris. 
This study was conducted as an observational study with case-control method, in 64 patients with severe acne, and as con-
trols 73 patients with mild acne and healthy people. Criteria based on Combined Acne Severity Classification. Biospesimen 
blood 1 ml taken from vena mediana cubiti then performed PCR and sequencing to determine the sequence of nucleotides 
in DNA fragments. The conclution from the study shows that polymorphisms of CYP1A1, CYP17, TNF-α genes and the 
interaction polimorphisms of CYP1A1, CYP 17 and TNF-α genes is not a risk factor for severe acne vulgaris, but polymor-
phism of CYP1A1 gene is a risk factor for acne vulgaris. 
Keywords: Severe Acne Vulgaris, Polymorphisms of CYP1A1, CYP17, and TNF-α genes, Interactions polymorphisms 
of CYP1A1, CYP 17 and TNF-α genes 
1. Introduction 
 Acne vulgaris (AV) is a common skin disease, as well as 
on our society in Indonesia 
(1)
. Acne does not threaten life 
but it often become a cosmetic problem in the form of se-
vere AV resulting scar formation, and often leads to psy-
chological complains, and even lead to lack of confidence 
in a person 
(1, 2)
. In a study conducted by Abdel-Hafez et al 
(2009) demonstrated psychiatric symptoms such as anxiety, 
depression, paranoia, and psychosis related to AV and 
showed negative effect on the quality of life of patients 
(3)
. 
Acne vulgaris is a chronic inflammatory pilosebaceous 
follicle disease, characterized by comedones, papules, pus-
tules, nodules, and sometimes scars. Acne primarily affects 
the face, neck, upper trunk and upper arms 
(4)
. Acne vulga-
ris is mainly found in adolescence and adulthood, and often 
at a younger age or older 
(1)
. In the United States this dis-
ease affects 40-50 million people each year 
(5)
, and the 
number of visits to the dermatologist are at 20% of all visits 
(6)
. From the medical record at several hospitals in Indone-
sia in 2008, obtained a high number of AV patients visits in 
some hospitals in Indonesia, among others, Dr Wahidin 
Sudirohusodo Hospital there were 22 visits (21% of all AV 
patient visit), in Dr. Moh. Hoesin Palembang Hospital there 
were 20 visits (6% of all AV patients visit), and Dr. Sardjito 
Yogyakarta Hospital there were 97 visits (9% of all AV 
patient visit) 
Acne can be caused by several factors, such as excess 
sebum production, follicular hyperkeratinization, prolifera-
tion of Propionibacterium acnes (P. acnes), inflammation, 
and genetics 
(7)
. 
Several genes that may influence the occurrence of AV 
including gene CYP 1A1, CYP 17 and TNF-α. Research 
conducted in Germany showed that CYP 1A1 gene poly-
morphisms causing the lack of an active natural retinoids 
resulting in follicular hiperkeratinization resulting AV 
(7)
. 
CYP17 gene that encodes cytochrome P450c17α is an en-
zyme in androgen biosynthesis that mediates the activity of 
steroid 17α-hydroxylase and 17, 20-lyase. The presence of 
CYP 17 gene polymorphism affects the activity of the en-
zyme CYP 17 that will change the levels of androgen, 
progesterone and estrogen hormones. Androgens increase 
sebum production and follicular keratosis which plays an 
important role in the development of acne 
(8)
. Tumor necro-
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sis factor-alpha (TNF-α) is one of the proinflammatory 
cytokines that initiate and regulate the flow of cytokines 
during the inflammatory response. The factors that cause 
changes in the production of TNF-α may influence the de-
gree of inflammation. The existence of polymorphism in 
the TNF-α gene can increase the production of TNF-α and 
aggravate AV 
(9)
. Expression of TLR2 and TNF-α by kera-
tinocytes induced by P. acnes in acne inflammatory phase 
(10)
. 
The results of CYP 1A1, CYP 17 and TNF-α gene poly-
morphisms in AV is still very limited, and the results of 
research that has been done in Makassar who get results are 
not statistically significant between CYP 17 gene polymor-
phisms and progression of severe acne, prompted us to per-
form research on gene polymorphisms CYP 1A1, CYP 
genes 17 and TNF-α genes and their interactions in AV. 
2. Material and Methods 
This study is an observational study with case-control 
method, in which the cases were severe acne patients and 
the controls were patients with mild acne and healthy 
people. The study was conducted in the Department of 
Dermatology and Venereology Hasanuddin University, Wa-
hidin Sudirohusodo Hospital and network hospitals, labora-
tory of Microbiology, Faculty of Medicine Hasanuddin 
University in Makassar, and laboratory Eijkman in Jakarta 
in March 2010-September 2011. 
The study population was divided into two characters, 
namely the case with the following inclusion criteria: pa-
tients with severe acne based on Combined Acne Severity 
Classification criteria, those are assessed by a dermatolo-
gist and patients signed the informed consent. While the 
excluded case criteria were: patients with severe acne who 
received antibiotics and anti-inflammatory medication for 1 
month, patients with severe acne who use hormonal contra-
ceptives, patient with severe acne who smoke, patients with 
severe acne who are pregnant and breastfeeding. Inclusion 
criteria for the control group were patients with mild acne 
and healthy people on the same age with the case and 
agreed to and signed informed consent. As for the exclu-
sion criteria for the control group were mild acne patients 
who received antibiotics and anti-inflammatory medication 
for 1 month, patients with mild acne who use hormonal 
contraceptives, patients with mild acne who are smokes, 
and patients with mild acne who are pregnant and breast-
feeding. Determination of the sample based on the table of 
Rochat et al, with OR = 3.5, the value of α = 0.05, β = 0.1, 
and f = 0.30 is 56. In this study, severe acne cases collected 
amount 64 people and control 73 people. 
Blood specimens were taken 1 mL of 64 patients with 
severe acne as cases and 73 patients with mild acne and 
healthy controls. The specimen will then be treated DNA 
isolation (sediment) for PCR testing. PCR method is pre-
pared using DNA extract as a positive control and sterile 
distilled water as a negative control. 
3. Results 
The number of samples in this study were 137 people 
consisting of 53 males (38.7%) and 84 females (61.3%). 
The sample consisted of 64 patients with severe AV, 31 
males (48.4%) and 33 females (51.6%) and 73 patients with 
mild AV and healthy individuals, 22 males (31.1%) and 51 
females (69.9%). 
Table 1 shows that from 64 people with severe AV, there 
were 31 (51%) who had a GG genotype, compared to 30 
(50%) with mild AV and healthy individuals. GA genotype 
in severe AV are at 30% compared to 70% in mild AV and 
healthy individuals. While the AA genotype in severe AV 
58.3% compared to 41.7% in light AV and healthy individ-
uals (statistical test p = 0.032). 
Table 1. Distribution of CYP1A1 genotype on the severe AV group and 
mild AV and healthy individuals group. 
Groups 
Genotype CYP 1A1 
Total (%) 
GG (%) GA (%) AA (%) 
Severe AV  31 (50,8) 12 (30,0) 21 (58,3) 64 (46,7) 
Mild AV and  
healthy individual 
30 (49,2) 28 (70,0) 15 (41,7) 73 (53,3) 
Total 61 (100,0) 40 (100,0) 36 (100,0) 137 (100,0) 
Note. Pearson Chi-Square p = 0,032 
Tabel 2 shows that from 64 people with severe AV, there 
were 20 (46,5%) who had CC genotype, compared to 23 
(53,5%) with mild AV and healthy individual. TC genotype 
exist in 44,7% severe acne compared to 55,3% in mild AV 
and healthy individual. While the TT genotype 48.9% in 
severe AV compared to 51.1% of mild AV and healthy indi-
viduals (statistical test p = 0.918). 
Tabel 2. Distribution of CYP17 genotype on the severe AV group and mild 
AV and healthy individuals group. 
Groups 
CYP 17 genotype 
Total (%) 
CC (%) TC (%) TT (%) 
Severe AV 20 (46,5) 21 (44,7) 23 (48,9) 64 (46,7) 
Mild AV and  
healthy individual 
23 (53,5) 26 (55,3) 24 (51,1) 73 (53,3) 
Total 43 (100,0) 47 (100,0) 47 (100,0) 137 (100,0) 
Note: Pearson Chi-Square p = 0,918 
Tabel 3 shows that from 64 people with severe AV, there 
were 3 (37,5%) who had AA genotype, compared to 5 
(62,5%) with mild AV and healthy individual. GA genotype 
exist in 55,6% severe acne compared to 44,4% in mild AV 
and healthy individual. While the GG genotype 46.7% in 
severe AV compared to 53.3% of mild AV and healthy indi-
viduals (statistical test p = 0.757) 
The results of analysis of the interaction between geno-
type, whether it is in the CYP 1A1, CYP 17, and TNF-α 
gene in severe AV, showed that the difference was not sta-
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tistically significant. 
Table 3. Distribution of TNF-α genotype on the severe AV group and mild 
AV and healthy individuals group. 
Groups 
TNF-α genotype 
Total (%) 
AA (%) GA (%) GG (%) 
Severe AV 3 (37,5) 5 (55,6) 56 (46,7) 64 (46,7) 
Mild AV and  
healthy individual 
5 (62,5) 4 (44,4) 64 (53,3) 73 (53,3) 
Total 8 (100,0) 9 (100,0) 120 (100,0) 137 (100,0) 
Ket: Pearson Chi-Square p = 0,757 
4. Discussion 
In this study found that the group with the genotype GG, 
GA and AA give a substantial proportion of the occurrence 
of cases of acne vulgaris (Table 1), but the proportion of 
cases with genotype AA higher than genotypes GG and GA. 
GG and GA genotype at position that gives the proportion 
of controls more than the AA genotype, this is a question to 
the results in Table 1. 
Combined genotypes GG and GA show properties AV 
protection against the occurrence of severe cases with ER 
of 0.85 (95% CI: 0.69 to 1.04). The fact shows the nature of 
which is not in line with expectations (GG and GA geno-
types as risk factors). The answer may lie in the selection of 
mild AV were included in the control group, it may be the 
genotypes GG and GA as the initial trigger pain (mild AV) 
should be grouped together with severe AV. Further analy-
sis of the patients with grouping mild and severe AV as 
cases and healthy individuals as controls. The results of the 
analysis between GG and AA genotype of CYP1A1 gene 
showed that individuals who have the GG genotype of 
CYP1A1 genes have ER 1.04 times (95% CI: 0.69 to 1.55) 
than individuals who have genotype AA CYP1A1 gene. 
The results of the analysis between GA and AA genotype of 
CYP1A1 gene showed that individuals who had GA geno-
type of CYP1A1 gene have ER 0.71 times (95% CI: 0.47 to 
1.07) than individuals who have genotype AA CYP1A1 
gene. The Further analysis showed true GG genotype as a 
risk factor and genotyping GA can not be proven as a risk 
factor for acne vulgaris. 
Theoretically, groups with genotypes GG and GA CYP 
1A1gene has a natural retinoid levels were lower than in 
the group with AA genotype. This occurance due to the 
increased activity of the enzyme in the metabolism and 
inactivation of ATRA to 4-oxo-retinoic acid, so that active 
natural retinoids will be reduced. Deficiency of active natu-
ral retinoids on the skin can cause abnormal differentiation 
and hiperkeratinization sebosit follicular canal (7). It is well 
known that vitamin A deficiency resulted in a variety of 
epithelial metaplasia is accompanied by an increase in cell 
proliferation and hyperkeratosis of the skin. From several 
studies in animals and infants with vitamin A deficiency, 
suggesting that vitamin A deficiency causes a disease re-
sembling follicular keratosis Darier and pityriasis rubra 
pilaris (11). Hiperkeratinization follicular epithelium is one 
important factor in the pathogenesis of acne (12).  
Study conducted by Paraskevaidis et al in Germany 
about the role of CYP 1A1 gene polymorphisms in acne 
showed normal frequency of m2 mutations from adenine to 
guanine substitution (A to G) result a change of isoleucine 
to valine amino acid which increases the activity of the 
enzyme. Another study focused on the development of can-
cer bronchogenic also found the effect of the polymorphism 
of CYP 1A1 gene by increasing the activity of the enzyme 
(7). 
Cytochrome P450c17 is an enzyme in the synthesis of 
sexual steroids. This enzyme catalyzes the 17α-
hydroxylation of pregnenolone and progesterone. Enzyme 
activity is required in the synthesis of androgens and estro-
gens. CYP17 gene is a gene that codes for this enzyme (13). 
Varian of polymorphic P450c17 gene (CYP17) encode this 
enzyme can lead to changes in the activity of CYP17 (14). 
The role of androgens in the pathogenesis of acne has 
been known. (8). There is evidence that androgenic stimu-
lation of sebaceous glands important role play in the occur-
rence of acne (15). However, the actual genetic reasons, 
how androgen effect on acne is still not clear (8). 
CYP17 gene in this research is done as study by He et al, 
in which the results obtained homozygous frequency C 
allele CYP17 gene in a group of severe AV in men was 
significantly higher than the control group. this study can 
be concluded that the homozigositosis CYP17-34C / C may 
increase the risk of severe acne in men (8).  
In this study, mutations of CYP17 gene occur with nuc-
leotide substitution T / C at the 5 'untranslated region (UTR) 
CYP17 promoter. Alleged that the substitution T / C will 
increase the rate of transcription of this enzyme in the CC 
genotype due to increased activity of promoters (14) and 
the consequence is an excessive production of glucocorti-
coids (13). Fiegelson and Haiman et al get estrogen levels 
were higher in women with the A2 allele (allele C) CYP17 
gene (16, 17). 
In this study was found the group with CC and TC geno-
type are not a risk factor for severe AV if compared with 
the TT genotype, although the CC genotype had higher 
androgen levels. Research by Cibula et al did not show a 
positive relationship between androgen production and 
severity of acne in women over the age of 17 years (18). 
Another study examined the association between CYP17 
gene polymorphism in women using PCR have also been 
carried out by Tian et al used 3 genotyping androgen-
related gene CYP 17 and the results showed significant 
results between the genotypes of androgen is A2, A2 of the 
CYP17 gene in 34 bp where there is a single base polymor-
phism on changes from T to C in the untranslated region 
(UTR) of the CYP17 gene. The effect of increased risk of 
acne in women with higher levels of androgens (19).  
This study found no statistical relationship polymor-
phism with severe AV because acne is a disease that is in-
fluenced by a variety of factors, mainly by environmental 
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factors. 
In this study the use of TNF-α gene promoter at position 
-308 and the obtained results from 64 people with severe 
AV, there are 3 people (37.5%) who had AA genotype, 
compared with 5 (62.5%) with severe AV and healthy indi-
viduals. GA genotype present in 55.6% severe AV com-
pared to 44.4% by mild AV and healthy individuals. While 
the GG genotype in severe AV compared with mild AV 46.7% 
and 53.3% of healthy individuals (statistical test p = 0.757). 
From these results it can be seen GG genotype frequency 
distributions predominantly found in the severe AV and 
mild groups and healthy individuals, and there was no sig-
nificant difference in genotype distribution in both groups 
so that it can be interpreted that there is no relationship 
between genotype distribution of TNF-α with severe AV. 
This is consistent with research conducted Baz K et al 
(2008) in 113 patients with acne, 30 of them with severe 
AV and GG genotype distribution obtained in 16 (53.3%), 
genotype GA in 12 (40.0%) and genotype AA in 2 (6.7%) 
compared with 32 patients with mild AV GG genotype dis-
tribution of 16 (50.0%), genotype GA 15 (46.8%) and the 
AA genotype 1 (3.2%) with the results of statistical tests (p 
= 0.463) (9). Based on statistical tests, our study found no 
significant association between TNF-α gene polymor-
phisms with severe AV events (p = 0.757). This suggests 
that TNF-α gene polymorphism is not a risk factor for se-
vere AV. In accordance with the results of the study in Tur-
key found the severity of acne vulgaris genotype was not 
associated with TNF-α. This can be caused by the expres-
sion of TNF-α genotype is associated with individual HLA 
(20) and is also influenced by the ethnic as found in the 
study by Baz K et al in several different ethnic, found also 
that the frequency of heterozygotes genotif G / A is very 
low on spare Asia (8-18%) when compared with research 
on European interest (27% -35.5%) (9). 
In this study, all the results of sequencing compared to 
full sequencing TNFα gene promoter along the 605 base-
pair (bp) referral of the gene bank using the BLAST pro-
gram (alert-2) from the webside: NBCI, and in our study 
with a sample of 64 patients with severe AV, we found 3 
(4.7%) mutations at position -308. Thus the discovery of 
the G allele frequency in TNF-α gene promoter -308 domi-
nant position when compared with the frequency of allele A. 
From the frequency distribution of genotypes, mutant AA 
genotype was found by 3 (4.7%) which is in line with re-
search conducted in Turkey Baz K et al who found 4 (3.5%) 
of 113 patients with acne mutations and research conducted 
by Szabo K et al in Romania that found 4 (1.8%) of 229 
patients with acne mutation (9, 21). Some research on the 
analysis of allele frequencies of TNF-α was reported by 
Szabo et al in position 1031 T> C,-857C> T,-863C> A,-
308G> A and-238g> A suspected role in the development 
of the inflammatory reaction in acne vulgaris . Results ob-
tained no significant differences in allele frequencies be-
tween cases and controls at the position -1031, -861, -238 
SNPs, whereas at position -857 and -308 obtained signifi-
cant results (p = 0.010) between allele C major and acne, as 
well as the minor allele at position -308 increased in pa-
tients with acne. G nucleotide replacement in the TNF-α 
gene at position -308 are associated with increased tran-
scriptional activity of TNF-α and increased levels of circu-
lating TNF-α (22). Substitution of guanine (G) to adenine 
(A) is also associated with increased susceptibility suffer-
ing from chronic inflammatory diseases, including acne 
vulgaris (9). Some diseases are associated with polymor-
phism in the TNF-α gene at position -308 one of them is 
breast cancer (23), chronic hepatitis B (22) dan schizophre-
nia (24) have been published. 
Various other related studies identified a single nucleo-
tide polymorphism in the TNF-α gene promoter humans 
have been reported, and found an association between in-
creased susceptibility to various diseases. Research in Chile 
by Cuenca J et al against TNF-α genotyping conclude that 
there is a difference in the spread of allele TNF-α and eth-
nic populations that have a high proportion of allele TNF-α 
is also likely to have increased the incidence of multiple 
metabolic diseases predisposing to chronic, degenerative 
diseases, inflammatory and autoimmune diseases. This 
indicates that there is a diversity of results of each minor 
alleles of several different tribes and populations and 
changes in one or two copies of chromosome 6 in the pro-
moter region of the TNF gene cluster contained in the HLA 
class III genes may lead to increased risk of various diseas-
es (25). From the results of our study and compared with 
some previous studies that have been published can be con-
cluded that TNF-α gene polymorphism at position -308 in 
touch with a person suffering from acne vulgaris vulnera-
bility, but not related to the degree of severity of acne vul-
garis. 
Therefore, further discussion is necessary to see the ef-
fects of retinoid therapy in severe AV group. Retinoid ther-
apy is given in the form of topical tretinoin 0.05 to 0.1% 
and / or oral isotretinoin. The proportion of patients with 
severe AV who got improvement after retinoid therapy, 
with GG genotype of CYP1A1 gene 50%, while those with 
the AA genotype of CYP1A1 gene as much as 42.9%. This 
suggests that administration of retinoids in severe AV pa-
tients with CYP1A1 gene polymorphisms provide a better 
outcome than severe AV patients without CYP1A1 gene 
polymorphisms, which are consistent with the theory that 
the group with the GG and GA genotypes of CYP 1A1 
gene has a lower natural retinoid levels than in group with 
the AA genotype, thus, giving retinoid provide improve-
ments in severe AV patients with CYP1A1 gene polymor-
phism. 
This study still remains questions thet has not been com-
pleted answered. From the three gene polymorphisms stu-
died, only further analysis of CYP1A1 gene polymor-
phisms showing the GG genotype of CYP1A1 gene as a 
risk factor for acne vulgaris. Theoretically, individuals with 
the GG genotype of CYP1A1 gene can be fall into active 
natural retinoid deficiency (7). Therefore, further discus-
sion is necessary to see the effects of retinoid therapy in 
severe AV group. Retinoid therapy is given in the form of 
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topical tretinoin 0.05 to 0.1% and / or oral isotretinoin. The 
proportion of patients with severe AV who got improve-
ment after retinoid therapy, with GG genotype of CYP1A1 
gene 50%, while those with the AA genotype of CYP1A1 
gene as much as 42.9%. This suggests that administration 
of retinoids in severe AV patients with CYP1A1 gene po-
lymorphisms provide a better outcome than severe AV pa-
tients without CYP1A1 gene polymorphisms, which are 
consistent with the theory that the group with the GG and 
GA genotypes of CYP 1A1 gene has a lower natural retino-
id levels than in group with the AA genotype, thus, giving 
retinoid provide improvements in severe AV patients with 
CYP1A1 gene polymorphism. 
The proportion of patients who experienced severe AV 
have repair after receive retinoid therapy with CC genotype 
CYP17 gene by 60%, while those with the TT genotype 
CYP17 gene as much as 42.9%. That administration of 
retinoids in patients with severe AV CYP17 gene polymor-
phism provides better results. Notice, in the group of the 
CYP17 gene with the CC genotype have higher androgen 
levels (18). There is evidence to convince that androgenic 
stimulation of sebaceous have role play in acne (15). In 
vitro, isotretinoin and ATRA is a potent inhibitor of cell 
proliferation and lipid synthesis in human sebosit and reti-
noids that decrease the synthesis of triglycerides and free 
fatty acids in the culture sebosit (26), so that administration 
of retinoid is expected to provide improvements in patients 
with severe AV the CYP17 gene polymorphism. 
The proportion of patients who experienced severe AV 
repair after receiving retinoid therapy with AA genotype of 
TNF-α gene as much as 33.3%, while those with GG geno-
type of TNF-α gene as much as 47.1%. That administration 
of retinoids in patients with severe AV with TNF-α gene 
polymorphism did not give better results than patients 
without severe AV TNF-α gene polymorphism. Theoretical-
ly, the G nucleotide substitution in the gene TNF-α -308 
locations with nucleotide A in individuals with the TNF-α 
gene polymorphisms resulting in elevated levels of TNF-α 
can influence the degree of inflammation and severity of 
acne (9). The role of retinoids in the treatment of AV is 
through keratolytic activity and regulation of proliferation 
and differentiation to eliminate comedones (27) and inhibit 
the secretion of the sebaceous glands (28) thereby granting 
retinoids can not be expected to provide more improvement 
in patients with severe AV gene polymorphisms of TNF-α 
than patients without severe AV TNF-α gene polymorphism. 
Overall the test results showed no significant probability 
value, however is still visible from the statistical test data 
showing the positive direction toward the severe AV. 
5. Conclusion 
CYP1A1 gene polymorphism is not a risk factor for se-
vere AV but it is a risk factor for acne vulgaris. CYP17 
gene and TNF-α polymorphism are not risks factor for se-
vere AV. The interaction between gene polymorphisms of 
CYP1A1, CYP17 gene and TNF-α gene is also not a risk 
factor for severe AV. It is need to perform a measurement of 
natural retinoids, the 4-oxo retinoic acid, the rate of sebum, 
the hormones androgen and TNF-α level in relation to the 
influence of CYP1A1 gene polymorphisms, gene CYP17 
and TNF-α gene expression in the creation of severe AV. 
Should be examined other genes that may play a role in the 
creation of heavy AV. 
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